| Year |
History |
| 1994 |
Electrophoretics International plc founded |
| 1995 |
Admission to AIM on LSE (from Rule 4.2) |
| 1996 |
INTRONN established - SMaRT™ modification of gene expression |
| 1998 |
Name changed to Proteome Sciences plc |
| 2001 |
Proteomics facility opened at King’s College, London |
| 2002 |
Acquisition of Aventis proteomics division, Frankfurt |
| Stroke biomarkers licensed to Biosite Inc. for Point of Care market |
| 2003 |
BSE biomarkers in blood licensed to IDEXX Inc. for live animal testing |
| Blood biomarker patent granted in US for lung, breast and oesophageal cancer |
| 2004 |
US blood biomarker patent granted for neuroblastoma and glioma |
